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Endocytosis of the IFNAR1 chain of Type 1 interferon receptor  
is regulated by diverse E2 ubiquitin conjugation enzymes
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Ubiquitination of signaling receptors triggers their endocytosis to restrict the extent of cell signaling. Type 1 interferon (IFN1) eliminates its 
receptor from cell surface via stimulating the ubiquitination of its IFNAR1 chain. While it was suggested that this ubiquitination aids  IFNAR1 
internalization via relieving a steric hindrance of a linear motif within IFNAR1 from the endocytic machinery, the mechanisms involved re-
main poorly understood. Here we describe a specific role for two disparate ubiquitin acceptor sites within this receptor. These sites, Lys501 
and Lys525 / 526, exhibit a preference for polyubiquitination via either Lys63- or Lys48-linked chains (K63-Ub and K48-Ub, respectively). 
Whereas the SCFβTrcp E3 ubiquitin ligase controls either type of ubiquitination-dependent IFNAR1 endocytosis, the specificity of these pro-
cesses is determined by two different E2 ubiquitin conjugating enzymes, Ubc13 and Cdc34. These enzymes can be directly used by SCFβTrcp E3 
ubiquitin ligase to generate either K63-Ub or K48-Ub in vitro. Ubc13 is involved in IFNAR1 endocytosis driven by the K63-Ub modification 
of Lys501, whereas the K48-Ub-specific Cdc34 affects receptor endocytosis via ubiquitin conjugation that occurs on Lys525 / 526. Both types 
of linkages combine to maximize IFNAR1 endocytosis otherwise suppressed by unfavorable conformation dependent on the presence of 
a conserved Pro470 within the intracellular domain of IFNAR1. We propose a model where alternate utilization of both E2s to assemble di-
verse polyubiquitin linkages cooperates to achieve IFNAR1 intracellular domain conformations and spatial arrangements that favor a maxi-
mal rate of receptor endocytosis.
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Endocytosis of cell surface signaling receptors is a key 
mechanism that controls the availability of these receptors 
to interact with the extracellular cognate ligands and, ac-
cor dingly, restricts the extent and duration of cellular respon-
ses to these ligands. Among post-translational modifications 
that contribute to this regulation is protein ubiquitination. 
This process of covalent attachment of ubiquitin poly pep-
tides involves the cascade of enzymatic reactions mediated 
by ubiquitin activating enzymes (E1), ubiquitin conjugating 
enzymes (E2) and ubiquitin ligases (E3, reviewed in [1]). 
Ubiquitination of receptors has emerged as a central 
mechanism that determines the efficacy of receptor 
endocytosis and downregulation [2–4].
The type of ubiquitination (mono-ubiquitination versus 
poly-ubiquitination and, in the latter case, the topology of 
the polyubiquitin chain) and its requirement for interna-
lization and / or post-internalization sorting varies greatly 
among different receptors. Numerous studies have high-
lighted the role of polyubiquitination via the Lys63-linked 
chains in controlling endocytosis of many cell surface 
proteins, including uracil permease [5], nerve growth factor 
receptor TrkA [6], MHC class II proteins [7], prolactin 
receptor [8], chimeric model endocytic proteins [9], the 
IFNAR1 chain of the Type 1 interferon (IFN1) receptor 
[10] and others.
Intriguingly, the rate of endocytosis of IFNAR1, a re-
ceptor that plays a key role in IFN1 signaling [11–13], was 
compromised by overexpression of either K63R or K48R 
ubiquitin mutants suggesting that polyubiquitination via 
both Lys63 and Lys48 linkage types (K63-Ub and K48-Ub, 
respectively) might be required [10]. IFNAR1 is a substrate 
for the SCFβTrcp E3 ubiquitin ligase, which is recruited to 
the receptor upon its phosphorylation within a specific 
phospho-degron [14, 15], and is capable of building both 
K63-Ub and K48-Ub on IFNAR1 in vitro [10]. Although 
ubiquitination can occur on many Lys residues within the 
intracellular domain of IFNAR1, a cluster of three lysines 
(Lys501, Lys525 and Lys526) receives a large share of 
ubiquitin conjugates [14] and the integrity of this cluster is 
required for efficient IFNAR1 endocytosis [10]. Ubiquiti-
nation of this cluster unmasks an adjacent Tyr466-based 
linear endocytic motif (otherwise blocked by IFNAR1- 
associated TYK2 Janus kinase), enabling its interaction with 
the AP2 adaptin complex and subsequent internalization 
via the clathrin-dependent pathway [10, 16]. While these 
studies suggest a model where ubiquitination of IFNAR1 
leads to either TYK2 dissociation or conformational changes 
within the intracellular domain of IFNAR1 (reviewed in 
[17, 18]), many critical questions remain unanswered.
Mass spectrometry analysis revealed the presence of 
K63-Ub and K48-Ub on wild type IFNAR1 [10], however 
it remains unclear whether both types of ubiquitin chains 
(or mixed chains) need to be assembled on IFNAR1 or on 
a putative endocytic regulator. Furthermore, the deter-
minants of topology specificity (including specific ubiquitin 
acceptors within the Lys501, 525, 526 cluster and specific 
E2 conjugation enzymes utilized by SCFβTrcp E3 ligase) are 
yet to be determined. Finally, the mechanism by which 
either type of ubiquitination contributes to the regulation 
of IFNAR1 endocytosis remains largely unknown.
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Here we focused on specific role of diverse E2 conjuga-
ting enzymes in mediating either K63-Ub or K48-Ub on 
different lysine acceptors within IFNAR1 in internalization 
of this receptor. Our data indicate that a combined effect of 
both types of linkages maximizes the rate of IFNAR1 
internalization and suggest that IFNAR1 ubiquitination 
may be conducive for the intracellular domain of IFNAR1 
to adopt a spatial conformation favorable for IFNAR1 
endocytosis.
Experimental procedures
Plasmids and cells
The constructs for expression of HA-tagged wild type, 
K48R, and K63R ubiquitin [19] were kindly provided by 
Yossef Yarden (Weitzmann Institute). Construct for expres-
sion of IFN-stimulated response element (ISRE) – driven 
luciferase [20] was a generous gift from Curt Horvath 
(North western University). Human IFNAR2 expression 
vector was kindly provided by John Krolewski (UC Irvine). 
Construct for expression of dominant negative Ubc13C87A 
mutant was provided by Zhijian J Chen (UT Southwestern). 
Vectors for the expression of N-terminal FLAG-tagged 
human IFNAR1 (wild type and K501, 525,526R mutants) 
were described previously [10]. These plasmids served as 
a backbone for generating additional N-FLAG-IFNAR1 
constructs for expression of K501R and K525,526 mutants 
using the site-directed mutagenesis; the results were verified 
by DNA sequencing. The shRNA constructs for knocking 
down bTrcp were described previously [8, 21]. The siRNA 
oligonucleotides for knocking down Cdc34 and Ubc13 were 
obtained from Sigma.
Human embryo kidney 293T cells, mouse embryo 
fibroblasts, and HeLa cells (ATCC) were grown in Dulbecco’s 
modified Eagles’s medium containing 10 % heat inactivated 
fetal bovine serum and Penicillin / Streptomycin. The stable 
U2OS-derivative cells lines for knock-in of ubiquitin or 
Ubc13 mutants were kindly provided by Zhijian J Chen. 
These cells were maintained and used as described previously 
[22]. Briefly, addition of tetracycline (1 μg / mL for 72 h) to 
these cells silences expression of either endogenous ubi-
quitin or endogenous Ubc13 concurrent with induction of 
expression of exogenous RNAi-resistant ubiquitin (wild 
type or K63R mutant) or Ubc13 (wild type or C87A 
catalytically inactive mutant). Cells were transfected with 
Lipofectamine Plus, Lipofectamine 2000, or Oligofectamin 
(Invitrogen) depending on the cell type and the experiment. 
For all transfections, empty vectors were included in the 
mixtures to maintain an equal amount of transfected DNA.
Chemicals, antibodies, reporter assays,  
and immunotechniques
Murine IFNβ was expressed in Chinese Hamster Ovary 
cells, and purified to homogeneity from conditioned culture 
medium using successive Blue Sepharose, copper chelating 
Sepharose, lentil lectin Sepharose, and Uno S (Biorad) catio-
nic ion exchange chromatographies. The specific activity 
of the protein was 2 × 108 units / mg in an in vitro antiviral 
cytopathic effect assay using murine L929 cells challenged 
with encephalomyocarditis virus. The purified protein had 
an endotoxin level of  < 0.05 EU / mg. Human IFNα2 (Roferon) 
was purchased from Roche. Cycloheximide and other 
chemicals were purchased from Sigma. Antibodies against 
FLAG (M2; Sigma), ubiquitin (FLys2; BIOMOL), HA 
(12CA5, Roche Boehringer Mannheim) were purchased. 
Secondary antibodies were obtained from Invitrogen and 
Roche Boehringer Mannheim. Immunoprecipitation and 
immunoblotting procedures were described previously [23–25].
For reporter assays, mouse embryo fibroblasts were 
 co-transfected with plasmids encoding human IFNAR2, 
ISRE-firefly luciferase (with a vector for constitutive 
expression of renilla luciferase), and various human IFNAR1 
constructs. 24 h post-transfection, cells were treated with 
human IFNa or mouse IFNβ (at 2000 U / mL) for 30 min. 
Then the media was removed and cells were incubated for 
24 h without IFN, harvested, and luciferase activity was 
determined using the Dual Luciferase Reporter Assay 
System (Promega). Data (normalized to renilla luciferase 
activity) from three independent experiments (each in five 
replicates) are presented in arbitrary units as Mean ± S. E. 
P values were calculated using the two-tailed Students’ 
 t-test.
IFNAR1 ubiquitination assays
In vitro ubiquitin ligation reactions were carried out as 
described previously [24] using SCFβTrcp purified from 293T 
cells as outlined elsewhere [26] and recombinant E2s 
including recombinant Cdc34 ( [27], a gift from Zhen-Qiang 
Pan, Mount Sinai School of Medicine) or 6His-Ubc13 / Uve1 
([28, 29], a gift from Ze’ev Ronai, The Burnham Institute). 
Briefly, 10 μl of packed beads carrying immobilized 
SCFβTrcp-HA was incubated with E1 (20 pmol), mCdc34 or 
6His-Ubc13 / Uve1 (1 nmol) in the reaction mixture (total 
volume 30 μl) that contained 50 mM Tris-HCl, pH 7.4, 5 mM 
MgCl
2
, 2 mM NaF, 2 mM ATP, 0.6 mM DTT, and 1 μg 
ubiquitin. The mixture was incubated at 37 °C for 60 min, 
boiled in 20 μl of Laemmli loading buffer, separated on 
SDS-PAGE and analyzed by immunoblotting.
For assessing in vivo ubiquitination of IFNAR1, the 
FLAG-tagged IFNAR1 species were expressed in 293T 
cells. Cells were harvested and lysed in 1 % NP40, 50 mM 
Tris pH 7.6, 150 mM NaCl, 1 mM NaVO
4
, 1mM PMSF, 
2.5 mM EDTA, Protease Inhibitor Cocktail (1:500; 
Sigma), 1 mM NaF, and 20 mM N-ethyl maleimide. The 
protein concentration was determined using the Bradford 
dye-binding assay. Equal amounts of protein lysates were 
incubated with M2-conjugated beads to immunoprecipitate 
the FLAG-tagged IFNAR1. The samples were washed 
three times with 50 mM Tris pH 7.4, 5 % glycerol, 1M 
NaCl and one time with 50 mM Tris pH 7.4, 5 % glycerol, 
150 mM NaCl and after boiling with SDS-containing 
Laemmli buffer, an aliquot from each sample was analyzed 
by M2 FLAG immunoblotting to normalize the receptor 
levels. Based on normalization, amounts of lysates that 
would yield comparable levels of IFNAR1 were separated 
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by SDS-PAGE and analyzed by immunoblotting using 
either anti-ubiquitin antibody (Biomol) or the chain-
specific anti-polyubiquitin, K63-Ub or K48-Ub antibodies 
(Millipore).
IFNAR1 internalization assays
Internalization of endogenous or exogenously expres-
sed IFNAR1 was determined using a high throughput 
fluorescence-based method described in detail elsewhere 
[10, 16]. Briefly, cells in 60-mm dishes were transfected 
with the indicated constructs or induced with tetracycline 
and plated equally on 24 well poly-D-lysine plates (Becton, 
Dickinson and Company). Cells were starved in serum-free 
Dulbecco’s Modified Eagle’s medium and were either 
treated with IFNa2a for the indicated time periods, or were 
kept on ice and not exposed to IFNa2a (time point 0). At 
given time points, the cells were washed, blocked, and 
incubated with the anti-IFNAR1 AA3 antibody [30] or 
anti-FLAG M2 antibody. The primary antibodies were then 
removed and the cells were washed extensively before 
adding a goat anti mouse IgG H + L horse radish 
peroxidase-conjugated antibody. Following another series 
of washes, the cells were incubated with AmplexRed Ultra 
Reagent 10-acetyl-3,7-dihydroxyphenoxazine (Molecular 
Probes). Aliquots were transferred to black 96-well plate 
(NUNC) and fluorescence was measured by reading with 
Beckman Coulter DTX880 Mutimode Detector plate 
reader using a 530 nm filter for excitation and a 590 nm 
filter for emission. Results were calculated using the 
following formula:
% Internalized = 100 – [(Vs – Vb) × t
n
 / (Vs – Vb) × t
0
] × 100,
where: Vs = Value of samples, Vb = Value of background 
(mock-transfected or probed with irrelevant antibody), 
t
n
 = time point n, t
0
 = time point 0.
Results
Given that that SCFβTrcp E3 ligase was shown to actively 
utilize Cdc34 E2 ubiquitin conjugating enzyme for K48-Ub 
of proteasomal substrates such as IκBα [27], we proposed 
a role for this E2 in IFNAR1 ubiquitination and endo-
cytosis. Conversely, whereas K63-linkage-specific ubiquiti-
nation of proteins in vitro can be achieved using a number 
of E2 enzymes, the ubiquitin-conjugating enzyme 13 (Ubc13, 
in complex with either Uev1A or Mms2) was shown to play 
a key role in assembling these linkages in vivo and in K63- 
dependent processes such as DNA recombination [31] and 
damage repair [32], and activation of signal transduction 
pathways [33–35].
We used the RNAi approach to determine the role of 
these E2s in IFNAR1 ubiquitination and internalization. 
Knockdown of Cdc34 inhibited K48-Ub of IFNAR1 
assessed by immunoblot using chain-specific antibody 
(Figure 1A). Conversely, K63-Ub of IFNAR1 was impaired 
in cells that received RNAi against Ubc13 (Figure 1A). 
Given that SCFβTrcp was capable of utilizing either of these 
enzymes for chain-specific ubiquitin ligation in vitro 
(Figure 1B) it is likely that both Cdc34 and Ubc13 may 
contribute to the regulation of IFNAR1 ubiquitination (via 
K48-Ub and K63-Ub, respectively) in cells. Accordingly, 
knockdown of either Cdc34 or Ubc13 noticeably slowed 
the kinetics of internalization of endogenous IFNAR1 in 
293T cells (Figure 1C). In addition, expression of the domi-
nant negative Ubc13 mutant (Ubc13C87A, [22]) inhibited the 
internalization rate of the N-terminally FLAG-tagged wild 
type IFNAR1 (Figure 1D). Collectively, these data suggest 
that function of both Cdc34 and Ubc13 is required for 
maximal rate of IFNAR1 endocytosis.
We then sought to characterize the cluster of ubiquitin 
acceptor sites within IFNAR1. While the triple K501R / 
 K525R / K526R (IFNAR13KR) mutant was shown to be 
deficient in overall ubiquitination [14], internalization and 
trafficking to the lysosomes [10], and degradation [14], the 
role of specific acceptors remained unclear. Our initial 
focus was on the putative “canonical” site represented by 
the Lys525 / 526 doublet located 9–10 amino acid residues 
proximal to the βTrcp binding site (
534
DSGNYS). This site 
is reminiscent of the Lys21 / 22 ubiquitin acceptor site 
within IκBα (Figure 2A) and fits the description of preferred 
ubiquitin acceptors for the SCFβTrcp E3 ligase (reviewed in 
[36]). Consistent with previously reported data [10], the 
internalization of the IFNAR13KR mutant was markedly 
inhibited. Intriguingly, mutation of either the canonical 
(Lys525 / 526) or the additional (Lys501) site resulted in an 
intermediate phenotype; these mutants internalized slower 
than wild type IFNAR1 but faster that the IFNAR13KR 
mutant (Figure 2B). This result indicates that both 
Lys525 / 526 and Lys501 sites within the ubiquitin acceptor 
cluster contribute to the maximal rate of IFNAR1 
endocytosis.
Based on these results we next aimed to determine 
whether ubiquitination of IFNAR1 on either canonical or 
additional site plays a role in regulating IFNAR1 stability 
and signaling. Proteolytic turnover of FLAG-IFNAR1 was 
assessed by a cycloheximide chase assay. IFNAR13KR 
mutant lacking both canonical and additional sites 
displayed a longer half-life compared to the wild type 
protein (Figure 2C). This result is consistent with previously 
reported data [14]. An intermediate turnover rates were 
observed for both K501R and K525 / 526R mutants (Figure 
2C) indicating that ubiquitination of both canonical and 
additional sites contributes to efficient degradation of 
IFNAR1.
To test whether these mutants were functional, we co-
expressed them together with human IFNAR2 in mouse 
embryo fibroblasts and assessed activation of the ISRE-
driven luciferase. Expression of human IFNAR1 proteins 
did not affect induction of luciferase by murine IFNβ that 
functions through the endogenous murine type 1 IFN 
receptor (Figure 2D, blue bars) indicating that IFN 
signaling downstream of receptors is not greatly perturbed 
by the expression of these human proteins. Whereas expres-
sion of wild type human IFNAR1 enabled transactivation 
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Figure 1. Role of Cdc34 and Ubc13 in IFNAR1 ubiquitination and endocytosis.
(А) Chain-specific polyubiquitination of FLAG-IFNAR1 proteins (purified from IFNα-stimulated 293T by immunoprecipitation) was analyzed by immunoblot using 
the anti-K63-ubiquitin and anti-K48-ubiquitin antibodies as well as antibody against FLAG (M2). Protein levels of endogenous Ubc13 or Cdc34 in the whole 
cell lysates (WCL) from these cells were measured by immunoblotting using indicated antibodies. An immunoblot for β-actin is included as a loading control.
(В) In vitro ubiquitin ligation reaction catalyzed by the SCFβTrcp E3 ubiquitin ligase (omitted as a negative control in the left lane) in the presence of either Cdc34 
or complex of Ubc13 / Uev1 was analyzed by immunoblot using the anti-ubiquitin Lys63 and anti-ubiquitin Lys48 antibodies as well as non-link-specific anti-
ubiquitin antibody (Ub). Levels of βTrcp were also analyzed.
(С) The effect of Cdc34 or Ubc13 knock down on the internalization of endogenous IFNAR1 in 293T cells treated with IFNα (6000 U / mL) for indicated time 
points was assessed using anti-IFNAR1 AA3 antibody and shown as a percentage of cell surface immunoreactivity loss calculated from three independent 
experiments (each in five replicates) as average ± S. E. M.
(D) The internalization kinetics of FLAG-IFNAR1 in 293T cells that received control vector (CTL, pCDNA3) or vector for expression of Ubc13C87A mutant 
treated with IFNα (6000 U / mL) for indicated time points was assessed using anti-FLAG antibody and shown as a percentage of cell surface immunoreactivity 
loss calculated from three independent experiments (each in five replicates) as average ± S. E.M
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of luciferase by a short pulse treatment with human IFNα, 
the expression of IFNAR13KR mutant robustly increased 
sensitivity of mouse cells to human Type 1 IFN. IFNAR1 
mutants lacking either the canonical or the additional site 
modestly yet significantly increased the effects of human 
IFNα (Figure 2D, black bars). These results suggest that 
ubiquitination on either canonical or additional sites 
contributes to attenuating the cellular responses to Type 1 
IFN likely through the regulation of IFNAR1 endocytosis 
and degradation.
Consistent with the previously reported role of βTrcp2 
in ubiquitination of endogenous IFNAR1 [10, 15], 
knockdown of this protein noticeably decreased the level 
of ubiquitination of FLAG-IFNAR1WT (Figure 3A). 
Furthermore, endocytosis of wild type IFNAR1 was also 
impaired in cells that received RNAi against βTrcp2 (Figures 
3B). Importantly, ubiquitination and internalization of 
IFNAR1 mutants lacking either K525 / 526 or K501 were 
also suppressed upon knockdown of βTrcp2 (Figures 3A – 
B). This result suggests that SCFβTrcp is responsible for 
ubiquitination of both canonical and additional sites within 
IFNAR1 and that efficient endocytosis of IFNAR1 relies 
upon concerted ubiquitination of these sites governed by 
the same E3 ubiquitin ligase.
Given that mutation of either canonical or additional 
sites does not dramatically alter overall ubiquitination of 
IFNAR1 (Figure 3A) yet noticeably affects its inter-
nalization (Figures 2B and 3B), degradation (Figure 2C) 
and signaling (Figure 2D), a qualitative difference between 
ubiquitination of these sites cannot be ruled out. Indeed, 
while quantitative mass spectrometry analysis of poly-
ubiquitin linkages revealed that wild type IFNAR1 is 
decorated with chains of both K63-Ub and K48-Ub types 
[10], a greater amount of K63-Ub linkages was found on 
the K525, 526R mutant (65 ± 18 fmole in FLAG-
IFNAR1K525, 526R versus 3 ± 0 fmole in FLAG-IFNAR1K501R; 
C.C. and S. Y.F. unpublished observations). The recent 
development of chain topology-specific antibodies has 
enabled us to seek corroboration of these findings. Probing 
of immunoblots containing immunopurified IFNAR1 
proteins with polyubiquitin chain-specific antibodies 
revealed that both chain types can be present on wild type 
IFNAR1 (Figures 1A and 3C). Intriguingly, mutation of the 
canonical site (Lys525, 526) decreased the levels of K48-Ub 
whereas the IFNAR1 mutant lacking the additional site 
(Lys501) displayed a deficient K63 linkage-specific signal 
(Figure 3C). Even considering that some ubiquitination 
may occur on the four other Lys residues within the 
Figure 2. Role of specific ubiquitin acceptor sites in the internalization and degradation of IFNAR1 and IFNAR1-mediated IFN signaling.
(А) Similarities in the primary determinants of βTrcp recruitment site and putative ubiquitin acceptor sites between human IFNAR1 and IκBα.
(В) Internalization rate of indicated FLAG-tagged IFNAR1 proteins expressed in 293T cells treated with IFNα (6000 U / mL) for indicated time points was 
assessed using anti-FLAG antibody and shown as a percentage of cell surface immunoreactivity loss calculated from three independent experiments (each in 
five replicates) as average ± S. E.M.
(С) Turnover rate of indicated FLAG-IFNAR1 proteins was determined in 293T cells treated with IFNα (6000 IU / mL) and cycloheximide (CHX, 20 µg / mL) 
for the indicated times. The percentage of IFNAR1 remaining signal (normalized per β-actin signal) relative to time point “0” (assigned a value of 100 %) are 
depicted below.
(D) Relative activity of ISRE-luciferase reporter expressed in mouse embryo fibroblasts that received human IFNAR2 (R2) and indicated human IFNAR1 
expression constructs and that were left untreated (white bars), treated with murine IFNβ (blue bars), or human IFNα (black bars). Normalized (per renilla 
luciferase activity) values from three independent experiments in arbitrary units are presented. Calculated p value (< 0.002) was obtained in comparison with 
WT receptor (single asterisk) or with WT, K501R or K525, 526 mutants (double asterisk)
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cytoplasmic domain of IFNAR1 that are outside of the 
investigated cluster, these data (together with Figure 1A) 
are suggestive of a scenario where two different ubiquitin 
acceptor sites may exhibit a preference for diverse types of 
poly-ubiquitination in a manner dependent on a specific 
E2 conjugating enzyme (Figure 3D).
We next investigated the importance of these different 
ubiquitin linkages conjugated to either canonical or 
additional sites in the regulation of IFNAR1 endocytosis. 
To this end, we used forced expression of ubiquitin mutants 
(K63R or K48R) that would prevent elongation of a specific 
chain in cells. Expression of these specific mutants 
attenuated the rate of internalization of wild type IFNAR1 
receptor by approximately 50 % (reference [10] and data 
not shown) and noticeably decreased the respective 
linkage-specific ubiquitination of IFNAR1, protein (Figure 
4A). Importantly, the expression of the K48R ubiquitin 
mutant (but not of K63R) further decreased the efficacy of 
internalization of IFNAR1K501R (Figure 4B). Conversely, 
endocytosis of IFNAR1K525,526R was affected by forced 
expression of K63R but not of the K48R ubiquitin mutant 
in 293T cells (Figure 4C).
The latter contribution of K63-linked chains in 
internalization of IFNAR1 is consistent with the reported 
role of this modification in the endocytosis of a number of 
other receptors (for example, TrkA [6]). Most of these 
studies, including our own work, in mammalian cells relied 
on forced expression of ubiquitin mutants that terminate 
elongation of chains of specific linkages. Recent 
development of isogenic U2OS derivatives in which 
tetracycline treatment confers knockdown of endogenous 
ubiquitin along with parallel expression of RNAi-insensitive 
recombinant ubiquitin (wild type or K63R mutant [22, 37]) 
enabled us to further determine the role of K63 linkage-
specific modifications in IFNAR1 internalization. 
Consistent with results obtained via forced ubiquitin 
expression, endocytosis of wild type IFNAR1 was 
compromised in cells expressing ubiquitinK63R (Figure 4D). 
Remarkably, these cells displayed a decrease in the 
internalization rate of the IFNAR1K525, 526R mutant but not 
Figure 3. βTrcp-dependent assembly of K63-Ub chains linked to Lys501 and K48-Ub chains conjugated to Lys525, 526 within IFNAR1.
(A) The ubiquitination of indicated FLAG-tagged IFNAR1 proteins in 293T cells that received either a shRNA control (shCON) or shRNA against βTrcp (shBTR) 
and were treated or not with IFNα (6000 IU / mL, 5 min) was analyzed by denaturing immunoprecipitation using the M2 antibody followed by immunoblotting 
with the anti-ubiquitin antibody. Inputs for each immunoprecipated sample were normalized to achieve comparable levels of IFNAR1. Protein levels of endogenous 
βTrcp and β-actin (included as a loading control) in these cells were also analyzed.
(B) Comparison of internalization rates in cells that received control shRNA against GFP (shCTL) or βTrcp (shBTR) for indicated FLAG-IFNAR1 proteins 
was performed as in Figure 2B.
(C) K48- and K63-specific polyubiquitination of indicated FLAG-tagged IFNAR1 proteins was analyzed as in panel A. The amount of FLAG tagged IFNAR1 
is included as a loading control.
(D) Summary of E2s and types of ubiquitin linkages involved in modification of the canonical and additional acceptor sites within IFNAR1
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of its K501R counterpart (Figure 4D). These results support 
the presence of the K63-linked chain on the Lys-501 
acceptor site. Taken together with protein ubiquitination 
data, these results indicate that ubiquitination of the 
canonical K525 / 526 site via K48-linked chains together 
with ubiquitination of K501 via the K63-linked chains 
enables maximal efficacy of IFNAR1 endocytosis.
To further test the hypothesis that diverse E2s may 
cooperate in contributing to IFNAR1 regulation via diverse 
site-specific ubiquitination we tested the effects of 
modulating E2s activities on IFNAR1 internalization. 
Knockdown of Cdc34 slowed the kinetics of internalization 
of endogenous IFNAR1 (Figure 1C) and of wild type 
FLAG-IFNAR1 expressed in 293T cells (Figure 5A). 
Intriguingly, whereas cells that received RNAi against 
Cdc34 also retarded internalization of FLAG-IFNAR1K501R 
mutant, endocytosis of FLAG-IFNAR1K525, 526R protein was 
not affected (Figure 5A). These data suggest that the role 
Figure 4. Disparate effect of ubiquitin mutants on the internalization of IFNAR1 proteins that contain either canonical or additional ubiquitin acceptor sites.
(A) Chain-specific polyubiquitination of wild type FLAG-IFNAR1 proteins co-expressed with indicated ubiquitin constructs and purified from IFNa-stimulated 
was analyzed as in panel 3A.
(B) The internalization kinetics of FLAG-IFNAR1WT co-expressed with wild type ubiquitin (WT, black line) was compared with that of FLAG-IFNAR1K501R co-
expressed with wild type ubiquitin (blue line), K63R ubiquitin (red line), or K48R ubiquitin (magenta line) in 293T cells. Assays were carried out as in Figure 2B.
(C) The internalization kinetics of FLAG-IFNAR1WT  co-expressed with wild type ubiquitin (WT, black line) was compared with that of FLAG-IFNAR1K525, 526R 
 co-expressed with wild type ubiquitin (red line), K63R ubiquitin (magenta line), or K48R ubiquitin (blue line) in 293T cells. Assays were carried out as 
in Figure 2B.
(D) The internalization kinetics of indicated FLAG-IFNAR1 proteins in U2OS cells induced to knock down endogenous ubiquitin and to re-express either wild 
type ubiquitin (solid lines) or K63R ubiquitin (dashed lines) were carried out as in Figure 2B
of K48-Ub in promoting efficient endocytosis of IFNAR1 
is facilitated by Cdc34-mediated ubiquitin conjugation to 
the canonical acceptor site (Lys525 / 526).
Given that Lys501 of IFNAR1 is ubiquitinated with the 
K63-Ub that requires Ubc13 (Figures 1A, 3C), we sought 
to determine whether this E2 was also a regulator of 
IFNAR1 endocytosis. Knockdown of Ubc13 noticeably 
inhibited the rate of internalization of wild type IFNAR1 
or the IFNAR1K525, 526R mutant but not of the K63-Ub-
deficient IFNAR1K501R mutant expressed in 293T cells 
(Figure 5B). In addition, forced expression of the dominant 
negative catalytically inactive mutant of Ubc13 (C87A) also 
decreased the efficacy of internalization of the canonical 
site-specific mutant and IFNAR1WT but did not alter the 
endocytosis of IFNAR1K501R (Figure 5C). These results 
suggest that Ubc13 contributes to the K63-Ub of the 
additional acceptor site (Lys501) and is important for 
efficient endocytosis of IFNAR1.
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Figure 5. A combined effect of Cdc34-mediated K48-Ub (assembled on Lys525, 526) and of Ubc13-mediated K63-Ub (assembled on Lys501) is required to 
achieve maximally efficient internalization of IFNAR1.
(A) The internalization kinetics of indicated FLAG-IFNAR1 proteins expressed in 293T cells that received control RNAi (siCTL) or RNAi against Cdc34 was 
analyzed as in Figure 2B.
(B) The internalization kinetics of indicated FLAG-IFNAR1 proteins expressed in 293T cells that received control RNAi (siCTL) or RNAi against Ubc13 was 
analyzed as in Figure 2B.
(C) The effect of the catalytically inactive mutant (C87A) of Ubc13 on the internalization of indicated FLAG-IFNAR1 proteins in 293T cells. Transfection of 
cells with pCDNA3 empty vector was used as a control (CTL). Analyses were carried out as in Figure 2B.
(D) The internalization kinetics of indicated FLAG-IFNAR1 proteins expressed in U2OS cells induced to knock down endogenous Ubc13 and re-express either 
wild type Ubc13 or the Ubc13C87A mutant. Analyses were carried out as in Figure 2B
We further sought to corroborate these conclusions 
using the U2OS-based cell lines that enable the inducible 
replacement of endogenous Ubc13 with recombinant (wild 
type or C87A mutant) proteins [22]. Internalization of 
FLAG-IFNAR1WT was clearly impaired in cells that re-
express catalytically active mutant of Ubc13 (Figure 5D). 
A similar result was observed on the K48-Ub-dependent 
IFNAR1 mutant lacking the additional site (Lys501) but 
not the K63-Ub dependent mutant (IFNAR1K525, 526R, 
Figure 5D). Taken together, these results suggest that 
Ubc13 facilitates an assembly of K63-linked chains on 
Lys501 of IFNAR1 and this modification cooperates with 
Cdc34-dependent K48-Ub on Lys525, 526 to contribute to 
efficient endocytosis of IFNAR1.
It has been previously shown that basal endocytosis of 
IFNAR1 in naïve human cells is inhibited by its association 
with TYK2 [38] that serves to shield a specific linear 
endocytic motif from interacting with the AP2 endocytic 
machinery complex (Figures 6A – B and Reference [16]). 
Exposure of cells to Type 1 IFN promotes the recruitment 
of βTrcp and ensuing ubiquitination of IFNAR1 [14, 15, 
39–41]. Overall, IFN-stimulated site-specific (K501, 525, 
526) ubiquitination of IFNAR1 was proposed to stimulate 
its internalization via unmasking this linear endocytic motif 
[10] in a manner that remains to be understood.
We next investigated putative mechanisms, through 
which ubiquitination of IFNAR1 may relieve the linear 
endocytic motif concealment. Given that association of 
TYK2 with IFNAR1 was similar for wild type receptor and 
ubiquitination-deficient IFNAR13KR mutant (Figure 6C), 
it seems unlikely that IFNAR1 ubiquitination may facilitate 
its dissociation from TYK2. Furthermore, while IFNAR1 
ubiquitination and internalization is stimulated by IFN [14, 
15, 39], it was shown that TYK2 remains associated with 
IFNAR1 throughout early endocytic events and trafficking 
stages in subcellular fractions from IFN-treated cells [42]. 
Thus, we considered an alternative model where IFNAR1 
ubiquitination may alter either conformation of its 
intracellular domain or its spatial arrangement with TYK2 
and plasma membrane. A highly conserved proline residue 
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distal to the endocytic motif (e. g. Pro470 in human 
IFNAR1, Figure 6A) may confer a polypeptide chain turn 
that permits the hindrance of the endocytic motif (Figure 
6B). Replacement of this Pro470 with Gly residue to enable 
chain flexibility generated the IFNAR1P470G protein that 
efficiently interacted with TYK2 (Figure 6C) yet exhibited 
a very high rate of internalization even in the absence of 
IFN treatment (Figure 6D). Strikingly, mutation of this 
proline residue within the ubiquitination-deficient IFNAR13KR 
largely restored the ability of this mutant to undergo efficient 
internalization (Figure 6E). These results suggest that 
IFNAR1 ubiquitination functions upstream of conforma-
tional / spatial alterations of the intracellular domain of 
IFNAR1 that ultimately favor efficient endo cytosis.
Discussion
Data presented here indicate that the maximal rate of 
IFNAR1 endocytosis is mediated collectively by the 
Figure 6. Combined ubiquitination of canonical and additional sites within IFNAR1 acts upstream of IFNAR1 conformational changes regulated by conserved 
Pro470.
(A) Conservation of a specific Pro residue (P470 in human IFNAR1, red letters) adjacent to the endocytic motif (bold letters, critical Tyr residue that interacts 
with AP2 is underlined) within IFNAR1 from indicated species.
A hypothetical model that proposes the role of proline-mediated IFNAR1 chain bend along with TYK2 association in masking the endocytic motif (red dot) from 
AP2 endocytic machinery complex. IFNAR1 ubiquitination is proposed to either dislodge TYK2 or affect spatial arrangements between the endocytic motif, 
plasma membrane and AP2.
(B) Indicated IFNAR1-FLAG (C-terminal tag) proteins with or without HA-tagged TYK2 were co-expressed in 293T cells. Upon IFN treatment (6000U / ml for 
10 min), the cells were harvested and lysed and the proteins were immunoprecipitated with anti-FLAG antibody. After a preliminary immunoblot with anti-FLAG 
antibody (not shown), different amount of reactions were loaded onto another gel to achieve a comparable level of FLAG-tagged IFNAR1 proteins in each lane. 
(C) These reactions were analyzed by immunoprecipitation-immunoblotting using the indicated antibodies. Levels of HA-TYK2 in the whole cell lysates (WCL) 
are also shown.
(D) Internalization rate of indicated FLAG-IFNAR1 expressed in 293T cells was analyzed as described in Figure 2B as well as in the absence of added IFNα 
(replaced with analogous volumes of PBS).
(E) Internalization rate of indicated FLAG-IFNAR1 expressed in 293T cells was analyzed as described in Figure 2B
K48-Ub attached to the Lys525, 526 ubiquitin acceptor 
sites and by the K63-Ub conjugated to the Lys501 site 
(Figures 2–5). Although SCFβTrcp controls the ubiquitin 
conjugation to the entire Lys cluster important for IFNAR1 
endocytosis (Figure 3), these events depend on alternate 
function of Cdc34 and Ubc13 E2 enzymes for promoting 
an ubiquitin chain topology-specific internalization (Figure 5).
The Cdc34-dependent conjugation of K48-Ub to the 
Lys525, 526 sites is consistent with observations reported 
previously for the proteasomal substrates of bTrcp [36]. 
Lysines 525 and 526 are located within 9–10 residues 
proximal from the bTrcp binding site (i. e. degron, 
534DSGNYS539) within IFNAR1. In that sense, they 
represent a canonical acceptor sites for the SCFβTrcp-
mediated ubiquitination similar to Lys21 / 22 within IκBα 
(Reference (14) and Figure 2A). Preference for such 
location of ubiquitin acceptor sites was indeed reported for 
bTrcp proteasomal substrate β-catenin [43] and introduc-
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tion of double lysine residues at a similar distance from the 
bTrcp-binding site converted the latent membrane protein 
1 of the Epstein-Barr virus from a pseudosubstrate to a bona 
fide bTrcp substrate [44]. The findings presented here are 
consistent with above mentioned similarities in acceptor 
site location between proteasomal substrates of SCFβTrcp 
and Lys525 / 526. These data further suggest that multi-
faceted interactions between SCFβTrcp, Cdc34 as an E2 
and either Lys21 / 22 within IκBα [27] or Lys525, 526 within 
IFNAR1 (this study) as a substrate might be conducive for 
the elongation of the polyubiquitin chain of K48-linked 
topology.
However, unlike IκBα which is a cytosolic protein and 
whose major ubiquitin acceptor sites Lys21 / 22 are located 
within a flexible N-terminal region [45], the choice of 
conjugation sites for IFNAR1 may be affected by the spatial 
constrains imposed by the anchoring of the transmembrane 
domain within the plasma membrane. Accordingly, SCFβTrcp 
may lack flexibility in the selection of either substrate lysine 
residues within IFNAR1 or the types of chains that can be 
preferentially built on these residues. Conversely, a different 
type of chain such as K63-Ub might be built by this E3 
ligase on the Ly-501 acceptor using an alternative to Cdc34 
E2 such as Ubc13. This possibility is consistent with the 
dependence of the maximal endocytic rate of the 
IFNAR1K525, 526R mutant on integrity of K63 within 
ubiquitin and on the levels and catalytic activity of Ubc13 
(Figures 4–5). Our results are first to demonstrate that 
SCFβTrcp can directly utilize Ubc13 / Uev1 complex as an E2 
enzyme to catalyze elongation of the K63-linked chain in 
vitro (Figure 1B). Accordingly, a similar mechanism that 
may occur in vivo would suffice as the simplest explanation 
for the βTrcp / Ubc13 / K63 chain-dependent IFNAR1 endo-
cytosis. However, it remains plausible that requirements for 
both βTrcp and Ubc13 for K63-linked ubiquitination on 
Lys501 within IFNAR1 reflect the indirect regulation and 
may involve additional E2s / E3s.
Possible roles for other E2 enzymes such as the 
promiscuous members of the UbcH5 family shown to be 
capable of ubiquitinating IFNAR1 in vitro [10] and 
demonstrated to play a role in mono-ubiquitination of 
substrates followed by elongation of either the K48-linked 
chain (via Cdc34, [27]) or the K63-linked chain (via 
Ubc13, [46]), are yet to be clarified. Whereas we did not 
observe a consistent change in the rate of IFNAR1 
endocytosis in cells that received RNAi reagents against the 
members of UbcH5 family (C.C. and S. Y.F., unpublished 
data), the role of these E2 species cannot be unequivocally 
ruled out.
It remains to be determined how these two types of 
polyubiquitin chains built on two different acceptor 
substrate lysines with the help of two different E2 enzymes 
may interact to unmask the linear endocytic motif and to 
maximize the rate of IFNAR1 internalization. On one 
hand, it is plausible that the extent of internalization is 
simply proportional to the overall levels of ubiquitin on the 
Lys501 / 525 / 526 cluster within IFNAR1, and both acceptor 
sites contribute to the sum by furnishing the type of chain 
that can be efficiently generated on a given substrate lysine 
residue because of the constrains of the substrate-ligase-E2 
interaction. On the other hand we cannot rule out that 
these different types of chains may play diverse functions in 
either recruiting or rearranging the receptor-interacting 
proteins and that these two functions are complementary 
in their effects on the IFNAR1 endocytosis rate.
Remarkably, enabling flexibility in the intracellular 
domain of IFNAR1 via replacing a highly conserved Pro470 
with Gly yields a receptor with a very high endocytic rate 
even in the absence of IFN1 stimulation. Furthermore, 
introduction of P470G substitution remarkably restored the 
internalization of a ubiquitination-deficient IFNAR13KR 
(Figure 6). This result suggests that ubiquitination of 
IFNAR1 stimulates its internalization most likely via 
altering a conformation / spatial arrangement of IFNAR1 
intracellular domain. In the context of this model, it is 
plausible that presence of two types of polyubiquitin chains 
on IFNAR1 may further promote the adoption of an 
endocytosis-permissive conformation. Given that the 
K63-Ub and K48-Ub chains adopt very different 
conformations [47], interactions between the endocytic 
motif and endocytic machinery could be augmented and / or 
stabilized by the presence of both chain types. Future 
structural studies are warranted to directly investigate this 
possibility.
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